Badic B, Morvan M, Quénéhervé L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N. Real World Data for Pancreatic Adenocarcinoma from a Population-Based Study in France. Cancers (Basel). 2023 Jan 15;15(2):525. doi: 10.3390/cancers15020525.
PMID: 36672474 (Pubmed)
Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study. Cancers (Basel). 2022 Oct 24;14(21):5208. doi: 10.3390/cancers14215208. PMID: 36358628 (Pubmed)
Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer. JAMA Netw Open. 2022 Oct 3;5(10):e2236666. doi: 10.1001/jamanetworkopen.2022.36666. PMID: 36239935 (Pubmed)
Reboux N, Cadieu E, Pruvost-Couvreur M, Cariou M, Kermarrec M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Quénéhervé L. Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer: A matched retrospective cohort study in a French area. Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101950. doi: 10.1016/j.clinre.2022.101950. Epub 2022 May 21. PMID: 35609825 (Pubmed)
Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Quénéhervé L. Ostomy prevalence and survival in elderly patients with stage III and IV rectal cancer. Geriatr Gerontol Int. 2021;21(8):670-675. PMID: 34189871 (Pubmed)
Bocciarelli C, Caumont C, Samaison L, Cariou M, Aline-Fardin A, Doucet L, Roudié J, Terris B, Merlio JP, Marcorelles P, Cappellen D, Uguen A. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories. Hum Pathol. 2021;114:99-109. PMID: 34019865 (Pubmed)
Tron L
Thomas F, Bouvier AM, Cariou M, Bouvier V, Jooste V, Pouchucq C, Gardy J, Quénéhervé L, Launoy G, Alves A, Eid Y, Dejardin O. Influence of non-clinical factors on restorative rectal cancer surgery: an analysis of four specialized population-based digestive cancer registries in France. Dig Liver Dis. 2021;S1580-8658(21)00364-9. PMID: 34301489 (Pubmed)
Bouvier AM, Jooste V, Sanchez-Perez MJ, Bento MJ, Rocha Rodrigues J, Marcos-Gragera R, Carmona-Garcia MC, Luque-Fernandez MA, Minicozzi P, Bouvier V, Innos K, Sant M; Working Group on Colorectum. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study. Dig Liver Dis. 2021;53:639-645. PMID: 33637435 (Pubmed)
Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Queneherve L. Prognostic factors for stage III colon cancer in patients 80 years of age and older. Int J Colorectal Dis. 2021;36:811-819. PMID: 33528749 (Pubmed)
Defossez G, Uhry Z, Delafosse P, Dantony E, d’Almeida T, Plouvier S, Bossard N, Bouvier AM, Molinié F, Woronoff AS, Colonna M, Grosclaude P, Remontet L, Monnereau A; French Network of Cancer Registries (FRANCIM).Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing. BMC Cancer. 2021 Jun 24;21(1):726. doi: 10.1186/s12885-021-08261-1. PMID: 34167516 (Pubmed)
Mulliri A, Gardy J, Cariou M, Launoy G, Robaszkiewicz M, Alves A, Bouvier V, Dejardin O. Care Management and Survival of Patients Diagnosed with Synchronous Metastatic Colorectal Cancer: A High-Resolution Population-Based Study in Two French Areas. Cancers (Basel). 2022 Mar 31;14(7):1777. doi: 10.3390/cancers14071777.
PMID: 35406549 (Pubmed)
Cariou M, El Fettouhi A, Kermarrec T, Bommelaere F, Foll Y, Nousbaum JB, Robaszkiewicz M, Quénéhervé L. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. Cancer Epidemiol. 2020;69:101839. PMID: 33096500 (Pubmed)
Bourhis A, De Luca C, Cariou M, Vigliar E, Barel F, Conticelli F, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Samaison L, Badic B, Doucet L, Troncone G, Uguen A. Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists? J Clin Pathol. 2020: jclinpath-2020-206496. (Pubmed)
Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB and The French Network of Cancer Registries (FRANCIM). Trends in incidence of small bowel cancer according to histology: a population-based study. J Gastroenterol 2020; 55: 181-8. (Pubmed)
Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, le Réseau Francim, Réseau des registres de cancer Francim. Descriptive Epidemiology of Cancer in Metropolitan France: Incidence, Survival and Prevalence. Bull Cancer 2019; 106: 617-34 (Pubmed)
Barel F, Cariou M, Saliou P, Kermarrec T, Auffret A ,Samaison L , Bourhis A, Badic B, Jézéquel J, Cholet F, Bail JP, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Doucet L, Uguen A. Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer. Sci Rep. 2019;9:8342. (Pubmed)
Barel F, Auffret A, Cariou M, Kermarrec T, Samaison L , Bourhis A, Badic B, Jézéquel J, Cholet F, Bail JP, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Doucet L, Uguen A. High Reproducibility Is Attainable in Assessing Histoprognostic Parameters of pT1 Colorectal Cancer Using Routine Histopathology Slides and Immunohistochemistry Analyses. Pathology 2019; 51: 46-54. (Pubmed)
Arnachellum R, Cariou M, Nousbaum JB, Jezequel J, Le Reste JY, Robaszkiewicz M. Pancreatic adenocarcinoma in the Finistere department, France, between 2002 and 2011 (1002 cases): population characteristics, treatment and survival. Pancreas. 2016;45:953-60 (Pubmed)
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010. (PubMed)
Gattolliat CH, Uguen A, Pesson M, Trillet K, Simon B, Doucet L, Robaszkiewicz M, Corcos L. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer. 2015 Feb;51(3):409-20. (PubMed)
Desgrippes R, Bouvier V, Delafosse P, Robaszkiewicz M, Molinié F, Trétarre B, Lepage C, Faivre J, Jooste V, Bouvier AM. Management of rectal cancer in France in a well-defined population. Eur J Gastroenterol Hepatol. 2014 Jul;26(7):743-7. (PubMed)
Pesson M, Volant A, Uguen A, Trillet K, De La Grange P, Aubry M, Daoulas M, Robaszkiewicz M, Le Gac G, Morel A, Simon B, Corcos L. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer. PLoS One. 2014 Feb 6;9(2):e87761. (PubMed)
Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L; French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique. 2014;62:95-108. (Pubmed)
Bouvier AM, Arveux P, Baldi I, Bouvier V, Dabakuyo S, Daoulas M et al. Quels sont les délais de prise en charge des cancers en france ? Etude menée à partir des registres de cancers. Bull Epidemiol Hebd. 2013;43-44-45: 581-9.
ETUDES EUROCARE
Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, et al. RARECAREnet working group. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017; 4. pii: S1470-2045 (Pubmed)
De Angelis R,, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, et al. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.Eur J Cancer. 2015;51:2254-2268.(Pubmed)
Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al. EUROCARE-5 Working Group. Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2242-2253. (Pubmed)
Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 Working Group:.Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. Eur J Cancer. 2015;51:2231-2241. (Pubmed)
Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M; EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. Eur J Cancer. 2015;51:2217-2230. (Pubmed)
Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, et al.; EUROCARE-5 Working Group. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.Eur J Cancer. 2015 ;51:2206-2216. (Pubmed)
Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M,et al. ; EUROCARE-5 Working Group. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study. Eur J Cancer. 2015;51:2191-2205. (Pubmed)
Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, et al.; EUROCARE-5 Working Group. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. Eur J Cancer. 2015;51:2179-2190. (Pubmed)
Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Working Group. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5. Eur J Cancer. 2015 ;51:2169-2178. (Pubmed)
Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci Set al.; EUROCARE-5 Working Group. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 – Results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2158-2168. (Pubmed)
Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al.; EUROCARE-5 Working Group . Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer. 2015;51:2144-2157. (Pubmed)
Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L; EUROCARE Working Group. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer. 2015;51:2130-2143. (Pubmed)
Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al.; EUROCARE-5 Working Group. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015;51:2120-2129. (Pubmed)
Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, et al. ; EUROCARE-5 Working Group. The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.Eur J Cancer. 2015;51:2104-2119. (Pubmed)
Minicozzi P, Bouvier AM, Faivre J, Sant M; Study working group. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients. Dig Liver Dis. 2014;46:645-51. (Pubmed)
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al.; EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15:23-34. (Pubmed)
ETUDES RARECARE
Lykoudis PM, Partelli S, Muffatti F, et al. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2019;45(1):46–51. (Pubmed) Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2019;45(1):75–80. (Pubmed)
Ray-Coquard I, Trama A, Seckl MJ, et al. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol. 2019;45(1):67–74. (Pubmed)
Gatta G, Trama A, Capocaccia R; RARECARENet Working Group. Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2019;45(1):3–11. (Pubmed)
Pasquali S, Bonvalot S, Tzanis D, et al. Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. 2019;45(1):31–39. (Pubmed)
Gatta G, Capocaccia R, Botta L, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study [published correction appears in Lancet Oncol. 2017 Aug;18(8):e433]. Lancet Oncol. 2017;18(8):1022–1039. (Pubmed)
ETUDES GROUPE EUROPEEN D’ETUDES HAUTE RESOLUTION SUR LE CANCER COLORECTAL
Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Christensen J, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tomšič S, Žagar T, Marques ALM, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Sánchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H.Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries. Lancet Reg Health Eur. 2022 Jul 6;21:100458. doi: 10.1016/j.lanepe.2022.100458. eCollection 2022 Oct. PMID: 35832063 (Pubmed)
Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Tybjerg AJ, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tomšič S, Žagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Sánchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H.Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):711-723. doi: 10.1016/S2468-1253(22)00084-X. Epub 2022 May 11. PMID: 35561739 (Pubmed)
Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. 2021;22(7):1002-1013. PMID: 34048685 (Pubmed)
Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, et al. European HR Working Group on colorectal cancer. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. 2020 Feb 21:S0748-7983(20)30125-6. (Pubmed)